Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9730554 | 0.76 | TSHR (0.42) | TSHRHSD17B10TDP1 | |
| SCHEMBL15247826 | 0.74 | TSHR (0.43) | TSHR | |
| SCHEMBL10691165 | 0.73 | TSHR (0.35) | TSHRHSD17B10 | |
| SCHEMBL9730393 | 0.72 | TSHR (0.39) | TSHRHSD17B10TDP1 | |
| SCHEMBL9507387 | 0.72 | TDP1 (0.42) | TSHRHSD17B10TDP1 | |
| SCHEMBL10593455 | 0.72 | TSHR (0.50) | TSHR | |
| SCHEMBL27858224 | 0.71 | SPHK1 (0.39) | TSHR | |
| SCHEMBL20055303 | 0.70 | TSHR (0.40) | TSHR | |
| SCHEMBL7967655 | 0.70 | TSHR (0.40) | TSHR | |
| SCHEMBL9153397 | 0.70 | TSHR (0.41) | TSHRHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1511498-B1 | A METHOD OF TREATING HUMAN SKIN AND A SKIN CARE COMPOSITION FOR USE IN SUCH A METHOD | PANTARHEI BIOSCIENCE BV (NL) | 2012-11-21 | — | — | EP | disclosed |
| EP-1390041-B1 | DRUG DELIVERY SYSTEM COMPRISING A TETRAHYDROXYLATED ESTROGEN FOR USE IN HORMONAL CONTRACEPTION | PANTARHEI BIOSCIENCE BV (NL) | 2009-11-25 | — | — | EP | disclosed |
| EP-1390042-B1 | DRUG DELIVERY SYSTEM COMPRISING A TETRAHYDROXYLATED ESTROGEN FOR USE IN HORMONAL CONTRACEPTION | PANTARHEI BIOSCIENCE BV (NL) | 2007-11-28 | — | — | EP | disclosed |
| EP-1390040-B1 | PHARMACEUTICAL COMPOSITION FOR USE IN HORMONE REPLACEMENT THERAPY | PANTARHEI BIOSCIENCE BV (NL) | 2007-01-03 | — | — | EP | disclosed |
| EP-1446128-B1 | USE OF ESTROGENIC COMPOUNDS IN COMBINATION WITH PROGESTOGENIC COMPOUNDS IN HORMONE-REPLACEMENT THERAPY | PANTARHEI BIOSCIENCE BV (NL) | 2006-12-06 | — | — | EP | disclosed |
| EP-1700602-A1 | Pharmaceutical composition for use in hormone replacement therapy | Pantarhei Bioscience B.V. (NL) | 2006-09-13 | — | — | EP | disclosed |
| EP-1390039-B1 | USE OF ESTROGEN COMPOUNDS TO INCREASE LIBIDO IN WOMEN | PANTARHEI BIOSCIENCE BV (NL) | 2006-03-15 | — | — | EP | disclosed |
| EP-1390039-A1 | USE OF ESTROGEN COMPOUNDS TO INCREASE LIBIDO IN WOMEN | Pantarhei Bioscience B.V. (NL) | 2004-02-25 | — | — | EP | disclosed |
| EP-1390040-A1 | PHARMACEUTICAL COMPOSITION FOR USE IN HORMONE REPLACEMENT THERAPY | Pantarhei Bioscience B.V. (NL) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002094275-A1 | USE OF ESTROGEN COMPOUNDS TO INCREASE LIBIDO IN WOMEN | PANTARHEI BIOSCIENCE B.V. (NL) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002094276-A1 | PHARMACEUTICAL COMPOSITION FOR USE IN HORMONE REPLACEMENT THERAPY | PANTARHEI BIOSCIENCE B.V. (NL) | 2002-11-28 | — | — | WO | disclosed |
| EP-1260225-A1 | A pharmaceutical composition for use in hormone replacement therapy | Pantarhei Bioscience B.V. (NL) | 2002-11-27 | — | — | EP | disclosed |